Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,224,395
-
Number of holders
-
203
-
Total 13F shares, excl. options
-
43,012,900
-
Shares change
-
+6,082,219
-
Total reported value, excl. options
-
$3,436,702,468
-
Value change
-
+$478,571,473
-
Put/Call ratio
-
82%
-
Number of buys
-
125
-
Number of sells
-
-54
-
Price
-
$80.04
Significant Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q1 2021
230 filings reported holding BEAM - Beam Therapeutics Inc. - COMMON STOCK as of Q1 2021.
Beam Therapeutics Inc. - COMMON STOCK (BEAM) has 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,012,900 shares
of 101,224,395 outstanding shares and own 42.49% of the company stock.
Largest 10 shareholders include FMR LLC (7,685,259 shares), ARK Investment Management LLC (4,779,104 shares), Temasek Holdings (Private) Ltd (3,406,013 shares), VANGUARD GROUP INC (3,233,410 shares), BlackRock Inc. (3,091,811 shares), Redmile Group, LLC (2,532,523 shares), MWG Management Limited (2,362,635 shares), HILLHOUSE CAPITAL ADVISORS, LTD. (2,072,679 shares), STATE STREET CORP (1,218,271 shares), and Casdin Capital, LLC (818,820 shares).
This table shows the top 203 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.